Center for Scientific Review; Amended Notice of Meeting, 15207 [2020-05424]

Download as PDF Federal Register / Vol. 85, No. 52 / Tuesday, March 17, 2020 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health Center for Scientific Review Amended Notice of Meeting National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Notice is hereby given of a change in the meeting of the HIV Immunopathogenesis and Vaccine Development Study Section, March 19, 2020, 8:00 a.m. to March 20, 2020 6:00 p.m., at the Fairmont Washington, DC, 2401 M Street NW, Washington, DC 20037, which was published in the Federal Register on February 20, 2020, 85 FR 9791. The meeting will be held at the National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892. The format of the meeting has been changed to a Video Assisted Meeting. The meeting date and time remain the same. The meeting is closed to the public. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Dated: March 11, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–05418 Filed 3–16–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Small Business: Cancer Drug Development and Therapeutics, March 23, 2020 08:00 a.m. to March 24, 2020, 06:00 p.m. Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 20852, which was published in the Federal Register on February 25, 2020, 85 FR 11376. The meeting location is being held at the National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. The meeting date and time remain the same. The meeting is closed to the public. Dated: March 11, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–05424 Filed 3–16–20; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 17:32 Mar 16, 2020 Jkt 250001 Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: March 30, 2020. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Allergy and Infectious Diseases, National Institutes of Health 5601 Fishers Lane, Room 3F52 Rockville, MD 20892 (Telephone Conference Call). Contact Person: Margaret A. Morris Fears, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52, Rockville, MD 20852, maggie.morrisfears@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: March 11, 2020. Tyeshia M. Roberson, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–05522 Filed 3–16–20; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, Small Business: The Cancer Biotherapeutics Frm 00099 Fmt 4703 Development (CBD), March 27, 2020 08:00 a.m. to March 27, 2020, 05:00 p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW, Washington, DC 20015, which was published in the Federal Register on March 4, 2020, 85 FR 12799. The meeting location is being held at the National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. The meeting date and time remain the same. Dated: March 11, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–05430 Filed 3–16–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the NHLBI Mentored Clinical and Basic Science Review Committee, March 19, 2020, 10:30 a.m. to March 20, 2020, 03:00 p.m., Holiday Inn National Airport Hotel, 2650 Jefferson Davis Highway, Arlington, VA 22202 which was published in the Federal Register on January 29, 2020, 85 FR 5219. The NHLBI IRG meeting is being amended due to a change in the meeting format. This two-day meeting to be held on March 19–20, 2020 will be a teleconference meeting. The meeting is closed to the public. Dated: March 11, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–05436 Filed 3–16–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 15207 Sfmt 4703 National Institute of Arthritis and Musculoskeletal and Skin Diseases; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel, which was published in the Federal Register on January 30, 2020, 85 FRN 5461. The NIAMS Special Emphasis Panel meeting is being amended due to a E:\FR\FM\17MRN1.SGM 17MRN1

Agencies

[Federal Register Volume 85, Number 52 (Tuesday, March 17, 2020)]
[Notices]
[Page 15207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05424]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, Small Business: Cancer Drug 
Development and Therapeutics, March 23, 2020 08:00 a.m. to March 24, 
2020, 06:00 p.m. Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 
20852, which was published in the Federal Register on February 25, 
2020, 85 FR 11376.
    The meeting location is being held at the National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892. The meeting date and 
time remain the same. The meeting is closed to the public.

    Dated: March 11, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-05424 Filed 3-16-20; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.